Microsoft's (MSFT) Surface Tablet Not Seen as a Threat to Apple's (AAPL) iPad - Jefferies
Get Alerts MSFT Hot Sheet
Price: $495.40 -0.3%
Rating Summary:
58 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
58 Buy, 11 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Microsoft's (Nasdaq: MSFT) new Surface tablet is not seen as competitive or a threat to Apple's (NASDAQ: AAPL) iPad, Jefferies' Peter Misek said.
"Though pricing details are unclear, we believe Microsoft will need to significantly undercut the iPad to be competitive," Misek said.
The analyst said the most important factor in the success of a tablet is its "ecosystem."
"Based on our discussions with developers, we find the lack of enthusiasm concerning and believe Windows 8 tablets will struggle to compete with the iPad, and to a lesser extent Android tablets such as the Galaxy Tab/Note," Misek said. He also said the two versions may cause some confusion for consumers.
Misek maintained his Buy rating and price target of $800 on Apple.
For an analyst ratings summary and ratings history on Apple click here. For more ratings news on Apple click here.
Shares of Apple closed at $585.78 yesterday.
"Though pricing details are unclear, we believe Microsoft will need to significantly undercut the iPad to be competitive," Misek said.
The analyst said the most important factor in the success of a tablet is its "ecosystem."
"Based on our discussions with developers, we find the lack of enthusiasm concerning and believe Windows 8 tablets will struggle to compete with the iPad, and to a lesser extent Android tablets such as the Galaxy Tab/Note," Misek said. He also said the two versions may cause some confusion for consumers.
Misek maintained his Buy rating and price target of $800 on Apple.
For an analyst ratings summary and ratings history on Apple click here. For more ratings news on Apple click here.
Shares of Apple closed at $585.78 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating
- Silence Therapeutics closes $201M public offering of ADSs
- Jefferies Starts Aehr Test Systems (AEHR) at Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share